Heidi Chow

Role

Senior campaigns and policy manager

Biography

Heidi leads Global Justice Now’s pharmceutical campaign to fight for access to medicines in the UK and across the world as well as the organisation's trade campaign. She has co-authored policy reports on the failings of the pharmaceutical innovation system and how it has left communities across the world without access to effective treatments. She has previously led and won the campaign to challenge the UK government's support for the New Alliance - an aid scheme that benefited corporations at the expense of Africa's small farmers. She has played an active role in the global movement for food sovereignty and in the development of the People's Food Policy. She has also campaigned on a range of economic justice issues such as food speculation, Europe’s bilateral trade deals, the World Trade Organisation and stopping RBS’s unethical investments. 

>>> Email Heidi

Latest posts

4 reasons we should be worried about big pharma's grip over publicly funded Covid-19 vaccines

Here are four reasons why we should be worried about big pharma’s grip over this publicly funded vaccine.

$2,340 for a Covid-19 treatment?

Yesterday US pharmaceutical company, Gilead announced that they will charge an extraordinary $2,340 for a five-day treatment course for the drug remdesivir, which is being used as a treatment for Covid-19. The drug has been developed with substantial amounts of public money in the US, with a reported $70.5 million of public investment

The race for a coronavirus vaccine proves big pharma isn't fit for purpose


18 March 2020

As the spread of coronavirus continues unabated, the response of the pharmaceutical industry is being thrust into the spotlight. For years, major public health crises have exposed the fundamental conflict between profit and public health in our pharmaceutical system.

Don’t be fooled by the government’s pledge to keep the NHS out of a Trump trade deal, these are just empty words

The government published its long-awaited negotiating objectives for a US-UK trade deal this week which included categorical statements that the NHS and drug prices are not on the table. But this does not represent a victory for all who want to protect our NHS.

Big tech companies have too much power. But Trump wants to lock it in


04 December 2019

The leaked trade papers from meetings between the US and UK revealed how a trade deal with the US could be used to create and lock-in new rules for the digital economy. The US government is pushing an agenda to protect big tech companies like Amazon, Google and Facebook from regulation.

A Trump trade deal could multiply the threat from 'corporate courts'

The US has insisted on the most extreme version of corporate courts in US trade talks – just like in TTIP, the EU-US trade deal we stopped in 2016.

Pages